Trial intelligence / Profile preview

Post-marketing incremental dose comparative study of Topina tablets in partial epilepsy

jRCT1080220856Phase 4

Sponsor
Kyowa Kirin
Start
Sep 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of topiramate in Focal Onset Epilepsy (2 arms), sponsored by Kyowa Kirin.

02

Drugs

topiramate
03

Conditions

Focal Onset Epilepsy

Beyond the preview

Go deeper on jRCT1080220856.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080220856.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call